Cargando…
Glycyl-L-Prolyl-L-Glutamate Pseudotripeptides for Treatment of Alzheimer’s Disease
So far, there is no effective disease-modifying therapies for Alzheimer’s Disease (AD) in clinical practice. In this context, glycine-L-proline-L-glutamate (GPE) and its analogs may open the way for developing a novel molecule for treating neurodegenerative disorders, including AD. In turn, this stu...
Autores principales: | Turkez, Hasan, Cacciatore, Ivana, Marinelli, Lisa, Fornasari, Erika, Aslan, Mehmet Enes, Cadirci, Kenan, Kahraman, Cigdem Yuce, Caglar, Ozge, Tatar, Abdulgani, Di Biase, Giuseppe, Hacimuftuoglu, Ahmet, Di Stefano, Antonio, Mardinoglu, Adil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835747/ https://www.ncbi.nlm.nih.gov/pubmed/33478054 http://dx.doi.org/10.3390/biom11010126 |
Ejemplares similares
-
Toxicity of Glycyl-l-Prolyl-l-Glutamate Pseudotripeptides: Cytotoxic, Oxidative, Genotoxic, and Embryotoxic Perspectives
por: Turkez, Hasan, et al.
Publicado: (2022) -
Molecular Genetics and Cytotoxic Responses to Titanium Diboride and Zinc Borate Nanoparticles on Cultured Human Primary Alveolar Epithelial Cells
por: Türkez, Hasan, et al.
Publicado: (2022) -
The Assessment of Selected miRNA Profile in Familial Mediterranean Fever
por: Kahraman, Cigdem Yuce, et al.
Publicado: (2021) -
Boron Nitride Nanoparticles Loaded with a Boron-Based Hybrid as a Promising Drug Carrier System for Alzheimer’s Disease Treatment
por: Yıldırım, Özge Çağlar, et al.
Publicado: (2022) -
Histidyl-Proline Diketopiperazine Isomers as Multipotent Anti-Alzheimer Drug Candidates
por: Turkez, Hasan, et al.
Publicado: (2020)